{
  "trial_id": "NCT01036594",
  "trial_group": "cancer",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race/ethnicity, histological confirmation of adenocarcinoma, testosterone levels, disease status (non-metastatic or metastatic), prior androgen deprivation therapy, prior antiandrogen therapy, Karnofsky Performance Status, prior radiation therapy, liver function tests (ALT, AST, Bilirubin), absolute neutrophil count (ANC), platelet count, creatinine levels, hemoglobin levels, prior chemotherapy status, prior ketoconazole/abiraterone/aminoglutethimide/corticosteroids use, use of supplements or complementary medicines, presence of second malignancy, presence of serious intercurrent infections, presence of psychiatric illnesses, presence of active or uncontrolled autoimmune disease, adrenal insufficiency status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race (NIH/OMB)",
          "race/ethnicity"
        ]
      ],
      "remaining_reference_features": [
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "histological confirmation of adenocarcinoma",
        "testosterone levels",
        "disease status (non-metastatic or metastatic)",
        "prior androgen deprivation therapy",
        "prior antiandrogen therapy",
        "Karnofsky Performance Status",
        "prior radiation therapy",
        "liver function tests (ALT, AST, Bilirubin)",
        "absolute neutrophil count (ANC)",
        "platelet count",
        "creatinine levels",
        "hemoglobin levels",
        "prior chemotherapy status",
        "prior ketoconazole/abiraterone/aminoglutethimide/corticosteroids use",
        "use of supplements or complementary medicines",
        "presence of second malignancy",
        "presence of serious intercurrent infections",
        "presence of psychiatric illnesses",
        "presence of active or uncontrolled autoimmune disease",
        "adrenal insufficiency status"
      ]
    },
    "processed-gen-response": "Age, sex, race/ethnicity, histological confirmation of adenocarcinoma, testosterone levels, disease status (non-metastatic or metastatic), prior androgen deprivation therapy, prior antiandrogen therapy, Karnofsky Performance Status, prior radiation therapy, liver function tests (ALT, AST, Bilirubin), absolute neutrophil count (ANC), platelet count, creatinine levels, hemoglobin levels, prior chemotherapy status, prior ketoconazole/abiraterone/aminoglutethimide/corticosteroids use, use of supplements or complementary medicines, presence of second malignancy, presence of serious intercurrent infections, presence of psychiatric illnesses, presence of active or uncontrolled autoimmune disease, adrenal insufficiency status."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Male, Race/Ethnicity, Customized, Region of Enrollment, Karnofsky Performance Status, Baseline PSA levels, Testosterone levels, Liver function tests (ALT, AST, Bilirubin), Absolute Neutrophil Count (ANC), Platelet count, Creatinine levels, Hemoglobin levels, Prior radiation therapy, Prior hormonal therapy,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Male",
          "Sex: Male"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Status",
        "Baseline PSA levels",
        "Testosterone levels",
        "Liver function tests (ALT, AST, Bilirubin)",
        "Absolute Neutrophil Count (ANC)",
        "Platelet count",
        "Creatinine levels",
        "Hemoglobin levels",
        "Prior radiation therapy",
        "Prior hormonal therapy"
      ]
    },
    "processed-gen-response": "Age, Sex: Male, Race/Ethnicity, Region of Enrollment, Karnofsky Performance Status, Baseline PSA levels, Testosterone levels, Liver function tests (ALT, AST, Bilirubin), Absolute Neutrophil Count (ANC), Platelet count, Creatinine levels, Hemoglobin levels, Prior radiation therapy, Prior hormonal therapy"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Karnofsky Performance Status, Race/Ethnicity, Customized, Region of Enrollment, Testosterone level, PSA level, Gleason score, Prior androgen deprivation therapy, Prior radiation therapy, Prior chemotherapy, Liver function tests (ALT, AST, Bilirubin), Absolute Neutrophil Count (ANC), Platelet count, Creatinine, Hemoglobin.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Race (NIH/OMB)",
          "Race/Ethnicity"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Ethnicity (NIH/OMB)"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Status",
        "Testosterone level",
        "PSA level",
        "Gleason score",
        "Prior androgen deprivation therapy",
        "Prior radiation therapy",
        "Prior chemotherapy",
        "Liver function tests (ALT, AST, Bilirubin)",
        "Absolute Neutrophil Count (ANC)",
        "Platelet count",
        "Creatinine",
        "Hemoglobin."
      ]
    },
    "processed-gen-response": "Age, Karnofsky Performance Status, Race/Ethnicity, Region of Enrollment, Testosterone level, PSA level, Gleason score, Prior androgen deprivation therapy, Prior radiation therapy, Prior chemotherapy, Liver function tests (ALT, AST, Bilirubin), Absolute Neutrophil Count (ANC), Platelet count, Creatinine, Hemoglobin."
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, race, Karnofsky Performance Status, histological subtype of prostate cancer, Gleason score, testosterone level, PSA level, number of metastatic sites, presence of bone metastases, liver function tests (ALT, AST, Bilirubin), absolute neutrophil count (ANC), platelet count, creatinine level, hemoglobin level.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Race (NIH/OMB)",
          "race"
        ]
      ],
      "remaining_reference_features": [
        "Sex: Female",
        "Male",
        "Ethnicity (NIH/OMB)",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "Karnofsky Performance Status",
        "histological subtype of prostate cancer",
        "Gleason score",
        "testosterone level",
        "PSA level",
        "number of metastatic sites",
        "presence of bone metastases",
        "liver function tests (ALT, AST, Bilirubin)",
        "absolute neutrophil count (ANC)",
        "platelet count",
        "creatinine level",
        "hemoglobin level"
      ]
    },
    "processed-gen-response": "Age, race, Karnofsky Performance Status, histological subtype of prostate cancer, Gleason score, testosterone level, PSA level, number of metastatic sites, presence of bone metastases, liver function tests (ALT, AST, Bilirubin), absolute neutrophil count (ANC), platelet count, creatinine level, hemoglobin level."
  }
}